Han Kyungdo, Kim Bongsung, Lee Seung Hwan, Kim Mee Kyoung
Department of Statistics and Actuarial Science, Soongsil University, Seoul, 06978, Korea.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Korea.
NPJ Parkinsons Dis. 2023 Jan 27;9(1):11. doi: 10.1038/s41531-023-00462-8.
There is growing evidence that patients with type 2 diabetes mellitus (DM) have an increased risk of developing Parkinson's disease (PD) and share similar dysregulated pathways. We aimed to determine whether the risk of PD increases as diabetes progresses among patients with type 2 DM. Using a nationally representative database from the Korean National Health Insurance System, 2,362,072 individuals (≥40 years of age) with type 2 DM who underwent regular health checkups during 2009-2012 were followed up until the end of 2018. The diabetes severity score parameters included the number of oral hypoglycemic agents, diabetes duration, insulin use, or presence of chronic kidney disease, diabetic retinopathy, or cardiovascular disease. Each of these characteristics was scored as one unit of diabetes severity and their sum was defined as a diabetes severity score from 0-6. We identified 17,046 incident PD cases during the follow-up. Each component of the diabetes severity score showed a similar intensity for the risk of PD. Compared with subjects with no parameters, HR values (95% confidence intervals) of PD were 1.09 (1.04-1.15) in subjects with one diabetes severity score parameter, 1.28 (1.22-1.35) in subjects with two parameters, 1.55 (1.46-1.65) in subjects with three parameters, 1.96 (1.82-2.11) in subjects with four parameters, 2.08 (1.83-2.36) in subjects with five parameters, and 2.78 (2.05-3.79) in subjects with six parameters. Diabetes severity was associated with an increased risk of developing PD. Severe diabetes may be a risk factor for the development of PD.
越来越多的证据表明,2型糖尿病(DM)患者患帕金森病(PD)的风险增加,且存在相似的失调途径。我们旨在确定2型糖尿病患者中,帕金森病风险是否会随着糖尿病进展而增加。利用韩国国民健康保险系统的全国代表性数据库,对2009年至2012年期间接受定期健康检查的2362072名(≥40岁)2型糖尿病患者进行随访,直至2018年底。糖尿病严重程度评分参数包括口服降糖药数量、糖尿病病程、胰岛素使用情况,或是否存在慢性肾病、糖尿病视网膜病变或心血管疾病。这些特征中的每一项都被计为一个糖尿病严重程度单位,其总和被定义为0至6的糖尿病严重程度评分。在随访期间,我们共识别出17046例帕金森病新发病例。糖尿病严重程度评分的每个组成部分对帕金森病风险的影响强度相似。与无参数的受试者相比,有一个糖尿病严重程度评分参数的受试者患帕金森病的HR值(95%置信区间)为1.09(1.04 - 1.15),有两个参数的受试者为1.28(1.22 - 1.35),有三个参数的受试者为1.55(1.46 - 1.65),有四个参数的受试者为1.96(1.82 - 2.11),有五个参数的受试者为2.08(1.83 - 2.36),有六个参数的受试者为2.78(2.05 - 3.79)。糖尿病严重程度与患帕金森病风险增加相关。严重糖尿病可能是帕金森病发生的一个危险因素。
NPJ Parkinsons Dis. 2023-1-27
J Affect Disord. 2024-4-15
J Clin Endocrinol Metab. 2018-9-1
Ann Allergy Asthma Immunol. 2018-8-19
Medicine (Baltimore). 2017-1
J Parkinsons Dis. 2021
Parkinsonism Relat Disord. 2022-7
NPJ Parkinsons Dis. 2025-7-1
NPJ Parkinsons Dis. 2025-6-4
Cells. 2025-5-14
Endocrinol Metab (Seoul). 2025-8
Diabetes Metab J. 2022-7
Endocrinol Metab (Seoul). 2022-2
Endocrinol Metab (Seoul). 2021-10
Endocrinol Metab (Seoul). 2021-10
Mov Disord. 2021-6
Metab Brain Dis. 2021-1